Captopril
Captopril
Captopril
Thermo Scientific Chemicals

Captopril

Orally active inhibitor of angiotensin-converting enzyme | CAS: 62571-86-2 | C9H15NO3S | 217.283 g/mol
Have Questions?
變更視圖buttonViewtableView
Quantity:
1 g
5 g
25 g
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
產品號碼 J63593.06
亦稱為 J63593-06
價格 (TWD)
-
申請報價
Quantity:
5 g
Request bulk or custom format
化學識別
CAS62571-86-2
IUPAC Name(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
Molecular FormulaC9H15NO3S
InChI KeyFAKRSMQSSFJEIM-RQJHMYQMSA-N
SMILESC[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
檢視更多
規格Specification Sheet規格表
FormPowder
Assay (HPLC)80.0% min.
Residue on ignition0.2% max
Melting Point104-110?C
Appearance (Color)White to off-white
檢視更多
Captopril has also been shown to inhibit the formation of angiotensin II, a bioactive peptide that stimulates angiogenesis and increases microvessel density. Captopril demonstrates noncompetitive inhibition of tyrosinase monophenolase activity and competitive inhibition of diphenolase activity

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Captopril has also been shown to inhibit the formation of angiotensin II, a bioactive peptide that stimulates angiogenesis and increases microvessel density. Captopril demonstrates noncompetitive inhibition of tyrosinase monophenolase activity and competitive inhibition of diphenolase activity

Solubility
Soluble in water (160 mg/ml) at 25°C, sesame and corn oils (<1mg/mL) at 25°C, methanol (>100 mg/ml), ethanol (>100 mg/ml), isopropanol (>100 mg/ml), chloroform (>100 mg/ml), and dichloromethane (>100 mg/ml).

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Keep away from strong oxidizing agents.
RUO – Research Use Only

General References:

  1. Andrew S Greene; Sandra L Amaral. Microvascular angiogenesis and the renin-angiotensin system. Current Hypertension Reports. 2002, 4 (1), 56-62 .
  2. N K Hollenberg. Renal implications of angiotensin receptor blockers. American Journal of Hypertension. 2001, 14, 237S-241S.